Cargando…
Expression, regulation and targeting of receptor tyrosine kinases in esophageal squamous cell carcinoma
Esophageal cancer is one of the most common types of cancer, which is a leading cause of cancer-related death worldwide. Based on histological behavior, it is mainly of two types (i) Esophageal squamous cell carcinoma (ESCC), and (ii) esophageal adenocarcinoma (EAD or EAC). In astronomically immense...
Autores principales: | Kashyap, Manoj Kumar, Abdel-Rahman, Omar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817798/ https://www.ncbi.nlm.nih.gov/pubmed/29455652 http://dx.doi.org/10.1186/s12943-018-0790-4 |
Ejemplares similares
-
Identification of spleen tyrosine kinase as a potential therapeutic target for esophageal squamous cell carcinoma using reverse phase protein arrays
por: Barbhuiya, Mustafa A., et al.
Publicado: (2018) -
The AXL receptor tyrosine kinase is associated with adverse prognosis and distant metastasis in esophageal squamous cell carcinoma
por: Hsieh, Min-Shu, et al.
Publicado: (2016) -
Icotinib derivatives as tyrosine kinase inhibitors with anti-esophageal squamous carcinoma activity
por: Chen, Xiaojie, et al.
Publicado: (2022) -
Cirsiliol targets tyrosine kinase 2 to inhibit esophageal squamous cell carcinoma growth in vitro and in vivo
por: Jia, Xuechao, et al.
Publicado: (2021) -
Targeting receptor tyrosine kinase signaling: Avenues in the management of cutaneous squamous cell carcinoma
por: Gopinatha Pillai, Mohan Shankar, et al.
Publicado: (2023)